Article

Metastasizing Basal Cell Carcinoma

Basal cell carcinoma (BCC) is the most common malignancy worldwide and is characterized by invasive growth and local tissue destruction. Cure rates for BCC exceed 90% with most treatment modalities. Metastasizing BCC (MBCC) is a rare complication of BCC with high morbidity and mortality rates. We report the case of a 66-year-old man with a large ulcerative lesion on the left side of the flank that was histopathologically diagnosed as a BCC. Clinical and imaging evaluations revealed substantial local invasion with regional lymph node, lung, liver, bone marrow, and bone metastasis. The patient died 7 months after the diagnosis was made. Potentially metastasizing BCCs cannot be definitely identified; thus early intervention with adequate treatment of all BCCs is advised.


 

Recommended Reading

Restrict Mohs surgery or risk drop in reimbursement
MDedge Dermatology
Mohs Appropriate Use Criteria
MDedge Dermatology
Don’t rush to lymph node biopsy for thin melanomas, expert says
MDedge Dermatology
Vismodegib prolongs positive response in advanced skin cancer
MDedge Dermatology
Inpatient dermatologist offers three rules to diagnose by
MDedge Dermatology
Ipilimumab’s long-term survival edge confirmed in melanoma
MDedge Dermatology
Novel PDT method proves superior for difficult AKs
MDedge Dermatology
Melanoma in Childhood: Changing Our Mind-set
MDedge Dermatology
Melanoma Arising in a Tattoo: Case Report and Review of the Literature
MDedge Dermatology
Gigapixel Photography for Skin Cancer Surveillance: A Novel Alternative to Total-Body Photography
MDedge Dermatology

Related Articles